European Biotech Acquisition Corp WT (EBACW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EBACW | ||||
| Company | European Biotech Acquisition Corp WT | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 0.5500 | ||||
| High | 0.7499 | ||||
| Low | 0.5000 | ||||
| Latest | 0.5150 | ||||
| Change | -0.0350 | ||||
| % Change | -6.36% | ||||
| Volume | 18,300 | ||||
| 20-Day Average Volume | 32,812 | ||||
| Previous Close | 0.5500 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 0.3907 | ||||
| 20-Day Raw Stochastic | 50.01% | ||||
| 20-Day Relative Strength | 58.77 | ||||
| Weighted Alpha | -27.55 | ||||
| Today's Opinion | 80% Buy | ||||
| Previous Opinion | 72% Buy | ||||
| Last Month's Opinion | 40% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.44% since 02/23/23 | ||||
| Low | 0.3020 on 03/01/23 | ||||
| High | 0.7499 on 03/02/23 | ||||
| 1-Month | |||||
| %Chg | +12.47% since 02/02/23 | ||||
| Low | 0.2800 on 02/13/23 | ||||
| High | 0.7499 on 03/02/23 | ||||
| 3-Month | |||||
| %Chg | +183.28% since 12/02/22 | ||||
| Low | 0.1234 on 12/20/22 | ||||
| High | 0.7499 on 03/02/23 | ||||
| 6-Month | |||||
| %Chg | +328.81% since 09/02/22 | ||||
| Low | 0.0800 on 09/28/22 | ||||
| High | 0.7499 on 03/02/23 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 342,895 | ||||
| Last Quarter Sales | 0 | ||||
| Last Quarter Net Income | -968,669 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||